A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma.
Saved in:
| Title: | A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma. |
|---|---|
| Authors: | Driscoll RK; Department of Neurological Surgery, University of Chicago Medicine, Chicago, Illinois, USA., Lyne SB; Department of Neurological Surgery, University of Chicago Medicine, Chicago, Illinois, USA., Voce DJ; Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Maraka S; Department of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, Illinois, USA., Gondi V; Proton Therapy Center and Northwestern Medicine Cancer Center, Warrensville, Illinois, USA., Chmura SJ; Department of Radiation and Cellular Oncology, University of Chicago Medicine, Chicago, Illinois, USA., Dixit KS; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Lou & Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Kumthekar PU; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Lou & Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Karrison TG; Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA., Pytel P; Department of Pathology, University of Chicago Medicine, Chicago, Illinois, USA., Collins JM; Department of Radiology, University of Chicago Medicine, Chicago, Illinois, USA., Stupp R; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Lou & Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.; Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Merrell RT; NorthShore University Health System, Evanston, Illinois, USA., Lukas RV; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Lou & Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Yamini B; Department of Neurological Surgery, University of Chicago Medicine, Chicago, Illinois, USA. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2024 Feb 01; Vol. 6 (1), pp. vdae014. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-2498 |
|---|---|
| DOI: | 10.1093/noajnl/vdae014 |
